Back to Trades
Posard Matthew L.
DirectorCIK 0001543792
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 5
- Buy transactions
- 0
- Sell transactions
- 10
- Companies
- 2
- Active
- 2026
Across 5 filings between 2026, Posard Matthew L., Director, has disclosed $3.6M in transactions — spread across 2 companies. Their disclosed trades are heavily weighted toward selling — $0 in buys and $3.1M in sells. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
5 loaded
| Nov 18 | HALO HALOZYME THERAPEUTICS, INC. | Posard Matthew L. | Director | Sell | $482.1K |
| Oct 2 | HALO HALOZYME THERAPEUTICS, INC. | Posard Matthew L. | Director | Sell | $567.7K |
| Sep 17 | HALO HALOZYME THERAPEUTICS, INC. | Posard Matthew L. | Director | Sell | $2.0M |
| Jun 22 | NAUT Nautilus Biotechnology, Inc. | Posard Matthew L. | Director | Award | $102.6K |
| May 7 | HALO HALOZYME THERAPEUTICS, INC. | Posard Matthew L. | Director | Grant | $397.9K |
5 filings